IP Library Granted Patent US 8,871,239
Granted Patent B2
US 8,871,239 · App. 13/544,043 · Granted Oct 28, 2014

Polymeric materials for medical devices

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,871,239
App. No.
13/544,043
Granted
Oct 28, 2014
Kind
B2
Abstract

The present invention includes biocompatible polymeric coatings, membranes, matrices, and films to be used with implantable medical devices. Medical devices containing such materials applied to a surface thereof contain a film-forming fluorous homo-polymer or copolymer containing the polymerized residue of a fluorous moiety, wherein the relative amounts of the polymerized residues of one or more moieties are effective to provide the coating and films with properties effective for use in coating implantable med devices.

Claims (6)

1. An implantable medical device having at least one pharmaceutical agent contained within a biocompatible coating applied to the device wherein said coating comprises a single, hydrophobic cross linked fluorous copolymer of polymerized residues of vinylidene fluoride, hexafluoropropylene, and perfluoropolyether, the copolymer having the formula P(VDF-co-HFP-co-PFPE), the coating modifying the surface of the medical device.

2. The implantable medical device of claim 1 wherein said device comprises a stent.

3. The implantable medical device of claim 1 wherein the at least one pharmaceutical agent comprises an anti-inflammatory agent.

4. The implantable medical device of claim 1 wherein the at least one pharmaceutical agent comprises an anti-restenotic agent.

5. The implantable medical device of claim 1 wherein the coating includes a therapeutic agent and an anti-thrombotic agent.

6. The implantable medical device of claim 1 wherein the molar ratio of the combined residues of VDF and HFP to perfluoropolyether is in a range from 0.95:0.05 to 0.1:0.9.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2025
From: CARDINAL HEALTH SWITZERLAND 515 GMBH; CARDINAL HEALTH 529, LLC; CORDIS CORPORATION; FLEXIBLE STENTING SOLUTIONS, INC
To: CORDIS US CORP
Reel/Frame 072987/0675 →
SECURITY INTEREST Recorded Oct 1, 2025
From: CORDIS US CORP.; ACCESS CLOSURE, LLC
To: HPS INVESTMENT PARTNERS, LLC
Reel/Frame 072973/0157 →